An alternative ARB, losartan, inhibited AAA formation in the Ang II/ApoE−/− model as evaluated by size and structural determination at sacrifice [13], and both ARBs telmisartan and valsartan limited PPE-induced aneurysm progression in rats [14], [15]. The gene discussed is APOE; the disease is triple-A syndrome.